LivaNova PLC Goodwill & Intangibles Disclosure
| Amortization Period in Years | December 31, | |||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||
| Finite-lived intangible assets: | ||||||||||||||||||||
| Customer relationships | 7 - 18 | $ | 190,850 | $ | 178,616 | |||||||||||||||
| Developed technology | 14 - 17 | 108,907 | 97,858 | |||||||||||||||||
| Trade names | 14,076 | 12,453 | ||||||||||||||||||
| Other intangible assets | 1,038 | 721 | ||||||||||||||||||
| Total gross finite-lived intangible assets | 314,871 | 289,648 | ||||||||||||||||||
| Accumulated amortization - Customer relationships | (107,785) | (90,895) | ||||||||||||||||||
| Accumulated amortization - Developed technology | (74,263) | (60,315) | ||||||||||||||||||
| Accumulated amortization - Trade names | (14,076) | (12,453) | ||||||||||||||||||
| Accumulated amortization - Other intangible assets | (783) | (691) | ||||||||||||||||||
| Total accumulated amortization | (196,907) | (164,354) | ||||||||||||||||||
| Net finite-lived intangible assets | $ | 117,964 | $ | 125,294 | ||||||||||||||||
| Indefinite-lived intangible assets: | ||||||||||||||||||||
| IPR&D | $ | 112,000 | $ | 112,000 | ||||||||||||||||
| Goodwill | 792,840 | 750,006 | ||||||||||||||||||
| Total indefinite-lived intangible assets | $ | 904,840 | $ | 862,006 | ||||||||||||||||
| 2026 | $ | 18,162 | ||||||
| 2027 | 17,763 | |||||||
| 2028 | 17,763 | |||||||
| 2029 | 17,652 | |||||||
| 2030 | 16,432 | |||||||
| Cardiopulmonary | Neuromodulation | Total | ||||||||||||||||||
As of December 31, 2023 | $ | 384,187 | $ | 398,754 | $ | 782,941 | ||||||||||||||
Foreign currency translation adjustment | (32,935) | — | (32,935) | |||||||||||||||||
As of December 31, 2024 | 351,252 | 398,754 | 750,006 | |||||||||||||||||
Foreign currency translation adjustment | 42,834 | — | 42,834 | |||||||||||||||||
As of December 31, 2025 | $ | 394,086 | $ | 398,754 | $ | 792,840 | ||||||||||||||
Want the next LivaNova PLC goodwill & intangibles disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment LivaNova PLC's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2019 | Mar 2, 2020 | |
| 2017 | Feb 28, 2018 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.